NASDAQ:IMRA

IMARA Stock Forecast, Price & News

$25.51

-3.49 (-12.03 %)

(As of 11/30/2020 12:00 AM ET)

Add

Compare

Today's Range

$24.30

Now: $25.51▼

$29.10

50-Day Range

$15.81

MA: $19.57▼

$29.00

52-Week Range

$13.40

Now: $25.51▼

$62.71

Volume29,903 shs

Average Volume60,278 shs

Market Capitalization$444.05 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Imara, Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. It develops IMR-687, which is an oral, once-a-day therapeutic for the treatment of sickle cell disease and b-thalassemia. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

3.5 Analyst's Opinion

Consensus Rating
IMARA has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $38.50, IMARA has a forecasted upside of 50.9% from its current price of $25.51.
Amount of Analyst Coverage
IMARA has received no research coverage in the past 90 days.

2.5 Community Rank

Outperform Votes
IMARA has received 13 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
IMARA has received 13 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
IMARA has received 50.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about IMARA and other stocks. Vote “Outperform” if you believe IMRA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IMRA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
IMARA does not currently pay a dividend.
Dividend Growth
IMARA does not have a long track record of dividend growth.

0.8 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, IMARA insiders have not sold or bought any company stock.
Percentage Held by Institutions
63.13% of the stock of IMARA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

Earnings Growth
Earnings for IMARA are expected to decrease in the coming year, from ($3.26) to ($3.46) per share.

Overall Beat the Market Rank^™

1.37 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Pharmaceutical preparations

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:IMRA

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.imaratx.com

Phone617-206-2020

Employees16

Debt

Debt-to-Equity RatioN/A

Current Ratio22.81

Quick Ratio22.81

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Outstanding Shares17,407,000

Market Cap$444.05 million

Next Earnings Date2/4/2021 (Estimated)

OptionableNot Optionable

$25.51

-3.49 (-12.03 %)

(As of 11/30/2020 12:00 AM ET)

30 days | 90 days | 365 days | Advanced Chart

Receive IMRA News and Ratings via Email

Sign-up to receive the latest news and ratings for IMRA and its competitors with MarketBeat's FREE daily newsletter.

IMARA (NASDAQ:IMRA) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of IMARA?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for IMARA in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for IMARA or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than IMARA?

Wall Street analysts have given IMARA a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but IMARA wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is IMARA's next earnings date?

IMARA is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for IMARA.

How were IMARA's earnings last quarter?

IMARA Inc. (NASDAQ:IMRA) posted its earnings results on Thursday, November, 5th. The company reported ($0.72) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.83) by $0.11.
View IMARA's earnings history.

What price target have analysts set for IMRA?

4 brokerages have issued 12-month price targets for IMARA's shares. Their forecasts range from $25.00 to $64.00. On average, they anticipate IMARA's stock price to reach $38.50 in the next year. This suggests a possible upside of 50.9% from the stock's current price.
View analysts' price targets for IMARA.

Who are some of IMARA's key competitors?

Some companies that are related to IMARA include Arcus Biosciences (RCUS), Mersana Therapeutics (MRSN), Stoke Therapeutics (STOK), Rocket Pharmaceuticals (RCKT), NGM Biopharmaceuticals (NGM), Revance Therapeutics (RVNC), Heron Therapeutics (HRTX), CytoDyn (CYDY), Zealand Pharma A/S (ZEAL), Keros Therapeutics (KROS), Epizyme (EPZM), Rhythm Pharmaceuticals (RYTM), Ligand Pharmaceuticals (LGND), MacroGenics (MGNX) and Athenex (ATNX).
View all competitors.

What other stocks do shareholders of IMARA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other IMARA investors own include Novavax (NVAX), Axsome Therapeutics (AXSM), OPKO Health (OPK), BioXcel Therapeutics (BTAI), Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), Dynavax Technologies (DVAX), Micron Technology (MU), Provention Bio (PRVB) and Abbott Laboratories (ABT).

Who are IMARA's key executives?

IMARA's management team includes the following people:

Dr. Rahul D. Ballal Ph.D., Pres, CEO & Director (Age 42, Pay $580.26k)
Mr. Michael P. Gray CPA, M.B.A., MBA, CPA, CFO & COO (Age 49, Pay $478.38k)
Mr. Frank Waligora, VP of Technical Operations
Mr. Stephen M. Migausky, Sr. VP of Legal & Gen. Counsel
Ms. Joelle Lufkin MPH, Sr. VP of Devel.

When did IMARA IPO?

(IMRA) raised $76 million in an IPO on Thursday, March 12th 2020. The company issued 4,500,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink served as the underwriters for the IPO.

What is IMARA's stock symbol?

IMARA trades on the NASDAQ under the ticker symbol "IMRA."

Who are IMARA's major shareholders?

IMARA's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (1.96%), State Street Corp (0.37%), California Public Employees Retirement System (0.23%), Charles Schwab Investment Management Inc. (0.18%), SG Americas Securities LLC (0.04%) and JPMorgan Chase & Co. (0.02%). Company insiders that own IMARA stock include Barbara Dalton and Bioscience Plc Arix.
View institutional ownership trends for IMARA.

Which institutional investors are selling IMARA stock?

IMRA stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., and Charles Schwab Investment Management Inc..
View insider buying and selling activity for IMARA.

Which institutional investors are buying IMARA stock?

IMRA stock was purchased by a variety of institutional investors in the last quarter, including State Street Corp, SG Americas Securities LLC, and California Public Employees Retirement System. Company insiders that have bought IMARA stock in the last two years include Barbara Dalton, and Bioscience Plc Arix.
View insider buying and selling activity for IMARA.

How do I buy shares of IMARA?

Shares of IMRA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is IMARA's stock price today?

One share of IMRA stock can currently be purchased for approximately $25.51.

How big of a company is IMARA?

IMARA has a market capitalization of $444.05 million. IMARA employs 16 workers across the globe.

What is IMARA's official website?

The official website for IMARA is www.imaratx.com.

How can I contact IMARA?

IMARA's mailing address is 116 HUNTINGTON AVENUE. 6TH FLOOR, BOSTON MA, 02116. The company can be reached via phone at 617-206-2020 or via email at [email protected]

This page was last updated on 12/1/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Get Started with MarketBeat

	Read Your Daily Newsletter
	Check Out My MarketBeat
	Watch Our Tutorial Videos
	Add a Stock to Your Watchlist
	Set Up an Instant Alert
	View a Company's Profile Page
	View Our Financial Calendars
	View Today's Analyst Ratings